Suchergebnisse - "Blick, Gary"

PubPharm (46)

1

Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings : Results from the TANDEM Study

enthalten in: Infectious diseases and therapy | 2024

von Schneider, S. | Blick, G. | Burke, C. | +13

2

Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study

enthalten in: Infectious diseases and therapy | 2024

von Schneider, S. | Blick, G. | Burke, C. | +13

3

Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I : A Systematic Literature Review and Meta-analysis

enthalten in: Open forum infectious diseases | 2023

von Kabra, M. | Barber, T. | Allavena, C. | +18

4

Mind the gap : An analysis of foregone health gains from unfunded cancer medicines in New Zealand

enthalten in: Seminars in oncology | 2016

von Evans, J. | Laking, G. | Strother, M. | +5

5

Exploring Social Networking Technologies as Tools for HIV Prevention for Men Who Have Sex With Men

enthalten in: AIDS education and prevention : official publication of the International Society for AIDS Education | 2015

von Ramallo, J. | Kidder, T. | Albritton, T. | +5

ErratumIn: AIDS Educ Prev. 2015 Oct;27(5):489-91 Grandeleski, Valen [corrected to Grandelski, Valen]. - PMID 26485237

6

Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1 : a randomized trial

enthalten in: JAMA | 2015

von Sulkowski, M. | Eron, J. | Wyles, D. | +22

CommentIn: JAMA. 2015 Mar 24-31;313(12):1217-8. - PMID 25705993

7

Dolutegravir versus placebo in subjects harbouring HIV-1 with integrase inhibitor resistance associated substitutions : 48-week results from VIKING-4, a randomized study

enthalten in: Antiviral therapy | 2015

von Akil, B. | Blick, G. | Hagins, D. | +24

8

Exploring Social Networking Technologies as Tools for HIV Prevention for Men Who Have Sex With Men

enthalten in: AIDS education and prevention | 2015

von Ramallo, J. | Kidder, T. | Albritton, T. | +4

9

Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1: A Randomized Trial

enthalten in: The journal of the American Medical Association / Englische Ausgabe | 2015

von Podsadecki, T. | Wang, C. | Slim, J. | +22

10

Safety and efficacy of ombitasvir - 450/r and dasabuvir and ribavirin in HCV/HIV-1 co-infected patients receiving atazanavir or raltegravir ART regimens

enthalten in: Journal of the International AIDS Society | 2014

von Eron, J. | Lalezari, J. | Slim, J. | +14

1
2
3
4
5
Nächster »
[5]